There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...
Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...
The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback